What Are Peptides? A Beginner's Guide to Peptide Science

Peptides are short chains of amino acids — typically between 2 and 50 residues — linked by peptide bonds. They are smaller than proteins but share the same building blocks. Peptides occur naturally in every living organism and play essential roles in biological signaling, immune defense, and tissue repair.

Unlike proteins, which fold into complex three-dimensional structures, most peptides are small enough to interact directly with cell receptors, making them highly specific in their biological effects. This specificity is what makes peptides so attractive to researchers and clinicians.

Peptides function primarily as signaling molecules. When a peptide binds to a receptor on a cell's surface, it triggers a cascade of intracellular events. This mechanism is similar to how hormones work — in fact, many hormones are peptides (insulin, for example, is a 51-amino-acid peptide).

The key mechanisms include:

• Receptor binding — Peptides bind to specific receptors on target cells, activating or inhibiting cellular pathways.
• Enzyme modulation — Some peptides influence enzyme activity, affecting metabolic processes.
• Gene expression — Certain peptides can upregulate or downregulate specific genes involved in growth, repair, and immune function.
• Neurotransmission — Neuropeptides act as chemical messengers in the nervous system, influencing mood, pain perception, and cognition.

The distinction between peptides and proteins is primarily one of size and complexity:

• Peptides: 2–50 amino acids. Generally linear or simple structures. Often act as signaling molecules.
• Proteins: 50+ amino acids. Complex 3D folding. Serve structural, enzymatic, and transport functions.

Some molecules blur this line — insulin (51 amino acids) is often called both a peptide and a protein. In practice, the term "peptide" in research contexts usually refers to molecules small enough to be synthesized in a lab and used therapeutically.

Researchers study peptides across several major categories:

• Growth hormone secretagogues — Peptides like Ipamorelin and Sermorelin that stimulate growth hormone release.
• Healing peptides — BPC-157 and TB-500 are studied for tissue repair and recovery.
• GLP-1 receptor agonists — Semaglutide and Tirzepatide are FDA-approved for weight management and diabetes.
• Neuropeptides — Selank and Semax are investigated for cognitive and anxiolytic effects.
• Antimicrobial peptides — LL-37 plays a role in innate immune defense.
• Anti-aging peptides — Epitalon and GHK-Cu are studied for their effects on telomeres and skin regeneration.

Several peptides have received FDA approval and are used clinically:

• Semaglutide (Ozempic, Wegovy) — Type 2 diabetes and weight management
• Tirzepatide (Mounjaro, Zepbound) — Type 2 diabetes and obesity
• Liraglutide (Saxenda, Victoza) — Weight management and diabetes
• Tesamorelin (Egrifta) — HIV-associated lipodystrophy
• Exenatide (Byetta, Bydureon) — Type 2 diabetes

Many other peptides remain in the research phase, available only for investigational use. Understanding the regulatory status of any peptide is essential before considering its use.

The most common administration routes for research peptides include:

• Subcutaneous injection — The most common method. A small needle delivers the peptide into the fat layer beneath the skin.
• Oral — Some peptides (like oral semaglutide) are formulated to survive digestion, though most peptides break down in the GI tract.
• Intranasal — Used for some neuropeptides (Selank, Semax) where direct CNS access is desired.
• Topical — Skin and hair peptides like GHK-Cu and Argireline are applied as creams or serums.

Peptide research is accelerating. The success of GLP-1 agonists for obesity has brought unprecedented attention and funding to the field. Key trends include:

• Multi-receptor agonists — Drugs like Retatrutide target GLP-1, GIP, and glucagon receptors simultaneously.
• Oral delivery — Advances in peptide formulation are making oral peptides more viable, reducing the need for injections.
• Personalized peptide therapy — As genomics advances, peptide treatments may be tailored to individual genetic profiles.
• AI-driven discovery — Machine learning models are being used to design novel peptides with specific therapeutic properties.

As the science matures, peptides are likely to play an increasingly important role in medicine — from metabolic disease to neurodegeneration to wound healing.